BCM
HLF icon

Bronte Capital Management’s Herbalife HLF Stock Holding History

Bronte Capital Management’s Portfolio HLF Stock Details HLF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.8M Sell
939,926
-180,249
-16% -$2.94M 1.37% 17
2025
Q4 		$14.4M Sell
1,120,175
-238,814
-18% -$2.53M 1.44% 16
2025
Q3 		$12.8M Sell
1,358,989
-864,794
-39% -$8.16M 1.15% 20
2025
Q2 		$21.6M Sell
2,223,783
-336,292
-13% -$2.5M 1.7% 14
2025
Q1 		$25.9M Buy
2,560,075
+960,907
+60% +$6.84M 2.1% 14
2024
Q4 		$10.7M Sell
1,599,168
-1,054,746
-40% -$7.84M 0.84% 18
2024
Q3 		$19.1M Sell
2,653,914
-42,694
-2% -$393K 1.55% 15
2024
Q2 		$28M Sell
2,696,608
-108,645
-4% -$1.09M 2.19% 16
2024
Q1 		$28.2M Sell
2,805,253
-297,464
-10% -$3.2M 2.3% 16
2023
Q4 		$47.3M Sell
3,102,717
-18,750
-0.6% -$259K 4.23% 9
2023
Q3 		$43.7M Buy
3,121,467
+104,567
+3% +$1.58M 4.4% 7
2023
Q2 		$39.9M Buy
3,016,900
+10,352
+0.3% +$141K 3.85% 8
2023
Q1 		$48.4M Buy
3,006,548
+368,653
+14% +$6.52M 5.62% 6
2022
Q4 		$39.3M Sell
2,637,895
-478,320
-15% -$8.33M 4.95% 6
2022
Q3 		$62M Buy
3,116,215
+119,554
+4% +$2.96M 7.72% 4
2022
Q2 		$61.3M Buy
2,996,661
+34,026
+1% +$841K 7.02% 4
2022
Q1 		$89.9M Buy
2,962,635
+207,063
+8% +$8.1M 7.56% 5
2021
Q4 		$113M Buy
2,755,572
+410,086
+17% +$17.1M 7.44% 5
2021
Q3 		$99.4M Buy
2,345,486
+91,625
+4% +$4.53M 7.27% 6
2021
Q2 		$119M Buy
2,253,861
+133,302
+6% +$6.63M 8.47% 5
2021
Q1 		$94.1M Buy
2,120,559
+59,314
+3% +$2.93M 10.67% 4
2020
Q4 		$99M Hold
2,061,245
– – 15.65% 2
2020
Q3 		$93M Sell
2,061,245
-22,617
-1% -$1.11M 16.39% 2
2020
Q2 		$93.7M Sell
2,083,862
-230,289
-10% -$8.94M 16.44% 2
2020
Q1 		$67.5M Buy
2,314,151
+784,759
+51% +$29.2M 11.05% 4
2019
Q4 		$72.9M Buy
1,529,392
+52,075
+4% +$2.26M 14.14% 3
2019
Q3 		$55.9M Buy
1,477,317
+405,473
+38% +$15.8M 15.47% 2
2019
Q2 		$45.8M Buy
1,071,844
+128,716
+14% +$6.09M 16.33% 3
2019
Q1 		$50M Buy
943,128
+6,383
+0.7% +$367K 18.75% 2
2018
Q4 		$55.2M Buy
+936,745
New +$51.7M 22.03% 2

Other funds holding HLF

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
ROIC
Route One Investment Company San Francisco, California $2.35B AUM 11.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Bronte Capital Management's HLF Position: Q1 2026 in Review

Bronte Capital Management reduced its Herbalife (HLF) stake by 16% in Q1 2026, selling an estimated $2.94M and leaving 939,926 shares worth $13.8M. The position accounts for 1.37% of the portfolio, ranked #17.

Bronte Capital Management first reported a position in HLF in Q4 2018 and has held it in 30 quarters since. The position peaked at $119M in Q2 2021. 252 funds tracked by Wall St. Rank hold HLF as of Q1 2026.

  • Bronte Capital Management held 939,926 shares of Herbalife worth $13.8M as of Q1 2026.
  • Bronte Capital Management sold 180,249 Herbalife shares in Q1 2026, an estimated $2.94M.
  • Herbalife made up 1.37% of Bronte Capital Management's portfolio in Q1 2026, its #17 holding.
  • Bronte Capital Management first reported a position in Herbalife in Q4 2018 and has held it in 30 quarters since.
  • Bronte Capital Management's Herbalife position peaked at $119M in Q2 2021.
  • 252 funds tracked by Wall St. Rank held Herbalife as of Q1 2026.

Based on Bronte Capital Management's 13F filing for Q1 2026, filed 27 Apr 2026.